161 related articles for article (PubMed ID: 36707288)
1. Comparison of amphotericin B lipid complex, deoxycholate amphotericin B, fluconazole, and anidulafungin activity against Candida albicans biofilm isolated from breakthrough candidemia.
Kraft L; Ribeiro VST; Gonçalves GA; Suss PH; Tuon FF
Enferm Infecc Microbiol Clin (Engl Ed); 2023 Dec; 41(10):596-603. PubMed ID: 36707288
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of anidulafungin, caspofungin, fluconazole and amphotericin B against biofilms and planktonic forms of Candida species isolated from blood culture in patients with hematological malignancies.
Malchikova A; Klyasova G
J Mycol Med; 2021 Sep; 31(3):101162. PubMed ID: 34147758
[TBL] [Abstract][Full Text] [Related]
3. Activities of fluconazole, caspofungin, anidulafungin, and amphotericin B on planktonic and biofilm Candida species determined by microcalorimetry.
Maiolo EM; Furustrand Tafin U; Borens O; Trampuz A
Antimicrob Agents Chemother; 2014 May; 58(5):2709-17. PubMed ID: 24566186
[TBL] [Abstract][Full Text] [Related]
4. Lack of efficacy of echinocandins against high metabolic activity biofilms of Candida parapsilosis clinical isolates.
Thomaz DY; Melhem MSC; de Almeida Júnior JN; Benard G; Del Negro GMB
Braz J Microbiol; 2020 Sep; 51(3):1129-1133. PubMed ID: 31898245
[TBL] [Abstract][Full Text] [Related]
5. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
6. Antifungal susceptibility profile of invasive
Memon S; Farooqi J; Zafar U; Naqvi SF; Zafar A; Jabeen K
J Med Microbiol; 2021 Dec; 70(12):. PubMed ID: 34878377
[No Abstract] [Full Text] [Related]
7. Proanthocyanidins polymeric tannin from Stryphnodendron adstringens are active against Candida albicans biofilms.
Luiz RL; Vila TV; de Mello JC; Nakamura CV; Rozental S; Ishida K
BMC Complement Altern Med; 2015 Mar; 15():68. PubMed ID: 25886244
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species.
Valentín A; Cantón E; Pemán J; Fernandez-Rivero ME; Tormo-Mas MA; Martínez JP
J Antimicrob Chemother; 2016 Dec; 71(12):3449-3452. PubMed ID: 27543657
[TBL] [Abstract][Full Text] [Related]
9. A 3-year study of
Sharifi M; Badiee P; Abastabar M; Morovati H; Haghani I; Noorbakhsh M; Mohammadi R
Front Cell Infect Microbiol; 2023; 13():1152552. PubMed ID: 37249981
[TBL] [Abstract][Full Text] [Related]
10. [Susceptibility of Candida albicans blood isolates to 3 antifungal drugs: retrospective study in Rio Grande do Sul, Brazil, 1999-2009].
Mattei AS; Alves SH; Mario DA; Watte G; Severo CB; Guazzelli Lda S; Oliveira Fde M; Severo LC
Rev Iberoam Micol; 2013; 30(4):243-7. PubMed ID: 23500157
[TBL] [Abstract][Full Text] [Related]
11. Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
Lindberg E; Hammarström H; Ataollahy N; Kondori N
Sci Rep; 2019 Mar; 9(1):3838. PubMed ID: 30846717
[TBL] [Abstract][Full Text] [Related]
12. Amphotericin B, fluconazole, and nystatin as development inhibitors of Candida albicans biofilms on a dental prosthesis reline material: Analytical models in vitro.
Bassi RC; Boriollo MFG
J Prosthet Dent; 2022 Feb; 127(2):320-330. PubMed ID: 33279153
[TBL] [Abstract][Full Text] [Related]
13. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
Rodriguez L; Bustamante B; Huaroto L; Agurto C; Illescas R; Ramirez R; Diaz A; Hidalgo J
PLoS One; 2017; 12(4):e0175172. PubMed ID: 28419092
[TBL] [Abstract][Full Text] [Related]
14. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E
Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300
[TBL] [Abstract][Full Text] [Related]
15. [In vitro activity of amphotericin B and anidulafungin against Candida spp. biofilms].
Valentín A; Cantón E; Pemán J; Quindós G
Rev Iberoam Micol; 2007 Dec; 24(4):272-7. PubMed ID: 18095759
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of liposomal amphotericin B and anidulafungin using an antifungal lock technique (ALT) for catheter-related Candida albicans and Candida glabrata infections in an experimental model.
Basas J; Palau M; Gomis X; Almirante B; Gavaldà J
PLoS One; 2019; 14(2):e0212426. PubMed ID: 30779771
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the antifungal activity of micafungin and amphotericin B against Candida tropicalis biofilms.
Marcos-Zambrano LJ; Escribano P; Bouza E; Guinea J
J Antimicrob Chemother; 2016 Sep; 71(9):2498-501. PubMed ID: 27147303
[TBL] [Abstract][Full Text] [Related]
18. Therapies against murine Candida guilliermondii infection, relationship between in vitro antifungal pharmacodynamics and outcome.
Paredes K; Pastor FJ; Capilla J; Sutton DA; Mayayo E; Fothergill AW; Guarro J
Rev Iberoam Micol; 2015; 32(1):34-9. PubMed ID: 24594291
[TBL] [Abstract][Full Text] [Related]
19. [Biofilm production and antifungal susceptibility patterns of Candida species].
Yücesoy M; Karaman M
Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
[TBL] [Abstract][Full Text] [Related]
20. Identification and susceptibility testing of oral candidiasis in advanced cancer patients.
Monsen RE; Kristoffersen AK; Gay CL; Herlofson BB; Fjeld KG; Hove LH; Nordgarden H; Tollisen A; Lerdal A; Enersen M
BMC Oral Health; 2023 Apr; 23(1):223. PubMed ID: 37072843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
